Physician profile
Douglas Grant
NPI 1922002542
$1,066.04
in general payments reported to CMS, 2019-2025
19 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $15.65 · 2021: $64.65 · 2022: $190 · 2023: $166 · 2024: $97.20 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $216.84 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $177.97 | 2019-2025 | Belbuca |
| Nevro Corp. | $110.57 | 2019-2023 | Senza |
| Abbvie INC. | $98.41 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.53 | 2019 | |
| Electronic Waveform Lab, INC. | $49.35 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.58 | 2022 | |
| Forte Bio-Pharma LLC | $30.14 | 2021-2022 | |
| Spr Therapeutics, INC | $29.33 | 2024 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $28.72 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $27.04 | 2022 | |
| Relievant Medsystems, INC. | $25.37 | 2023 | Intracept |
| Saluda Medical Americas, INC. | $25.35 | 2025 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.39 | 2019 | |
| Abbott Laboratories | $20.44 | 2023 | Proclaim |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $19.60 | 2019 | |
| Grt US Holding, INC. | $18.89 | 2022 | |
| Redhill Biopharma INC. | $18.12 | 2022 | |
| Nalu Medical, INC. | $16.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.